Related Experiment Video
Updated: Aug 9, 2026

Isolation of Human Islets from Partially Pancreatectomized Patients
Published on: July 30, 2011
Low frequency of p16(INK4a) alterations in insulinomas
D K Bartsch1, M Kersting, A Wild
1Department of Surgery, Philipps University, Marburg, Germany. bartsch@mailer.uni-marburg.de
Background/Aims:
The molecular mechanisms contributing to the tumorigenesis of insulinomas are poorly understood. Disruption of the cell cycle due to inactivation of the p16(INK4a) tumor-suppressor gene was identified in a variety of human tumors, including gastrinomas and nonfunctioning endocrine pancreatic carcinomas. In this study the role of p16(INK4a) in the tumorigenesis of insulinomas was evaluated.
Methods:
Seventeen insulinomas (14 benign, 3 malignant) were analyzed for genetic alterations in the p16(INK4a) tumor-suppressor gene by SSCP, PCR-based deletion and methylation-specific assays. p16 expression was determined by immunohistochemistry.
Results:
One malignant insulinoma showed a homozygous deletion of p16(INK4a) and another two benign insulinomas revealed aberrant methylation of the p16(INK4a) promoter region. All three tumors lacked p16 expression according to immunohistochemistry. None of the insulinomas carried intragenic p16(INK4a) mutations. In total, 17% of insulinomas had p16(INK4a) alterations.
Conclusions:
The p16(INK4a) tumor-suppressor gene contributes to tumorigenesis in only a small subset of insulinomas.
Insights
The p16(INK4a) tumor-suppressor gene plays a role in a small fraction of insulinoma tumorigenesis. Genetic alterations like deletion and methylation of p16(INK4a) were found in 17% of tumors studied.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Insulinoma tumorigenesis mechanisms are not fully understood.
- The p16(INK4a) tumor-suppressor gene is crucial in cell cycle regulation and is implicated in various cancers.
- Previous studies linked p16(INK4a) inactivation to gastrinomas and pancreatic carcinomas.
Purpose of the Study:
- To investigate the role of the p16(INK4a) tumor-suppressor gene in the development of insulinomas.
- To evaluate genetic alterations and expression of p16(INK4a) in insulinoma samples.
Main Methods:
- Seventeen insulinoma samples (14 benign, 3 malignant) were analyzed.
- Genetic alterations in p16(INK4a) were assessed using Single-Strand Conformation Polymorphism (SSCP), PCR-based deletion assays, and methylation-specific assays.
- p16 protein expression was evaluated via immunohistochemistry.
Main Results:
- Aberrant methylation of the p16(INK4a) promoter was observed in two benign insulinomas.
- A homozygous deletion of p16(INK4a) was detected in one malignant insulinoma.
- All three tumors with genetic alterations showed a lack of p16 expression; no intragenic mutations were found. Overall, 17% of insulinomas exhibited p16(INK4a) alterations.
Conclusions:
- The p16(INK4a) tumor-suppressor gene is involved in the tumorigenesis of a small subset of insulinomas.
- Genetic alterations, specifically deletion and promoter methylation, contribute to p16(INK4a) inactivation in some insulinomas.

